Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, September 7, 2015

Newer devices reduce aspiration times, improve outcomes after stroke treatment

And once again these supposedly smart people do not discuss anything about solving the neuronal cascade of death.  Does no one have two functioning neurons to rub together?
http://www.healio.com/cardiology/intervention/news/online/%7B2a000be6-74c8-4c1d-874c-c61dae654e75%7D/newer-devices-reduce-aspiration-times-improve-outcomes-after-stroke-treatment?utm_source=maestro&utm_medium=email&utm_campaign=cardiology%20news

The use of newer, larger catheters for endovascular treatment of acute ischemic stroke was associated with shorter aspiration time and improved functional outcomes, according to data presented at the Society for NeuroInterventional Surgery Annual Meeting.
Researchers evaluated data on 932 patients (mean age, 66 years) with stroke who underwent endovascular treatment with the Penumbra Aspiration System (Penumbra Inc.). The patients were culled from six prospective and retrospective trials of the device.
“The aim … was to evaluate if there was a corresponding improvement in procedural times over the course of the evolution of these devices,” the researchers wrote in the abstract.
Outcomes of interest included clinical outcomes at 90 days, as indicated by modified Rankin scale, and aspiration time.
All patients received treatment within 8 hours of stroke onset. The mean time to presentation was 2.1 hours and the mean time to groin access was 4.4 hours. Upon admission, patients had a median NIH Stroke Scale score of 18 and a TIMI score of 0 to 1. The middle cerebral artery accounted for three-quarters of vessel locations.
After undergoing endovascular treatment, 84% of patients achieved revascularization to a TIMI score of 2 to 3.
Factors associated with shorter aspiration time included female sex, use of larger catheters, and timely presentation and treatment, according to univariable analysis. Shorter aspiration time was associated with improved outcomes (P = .0044). Younger patients, women, those with a lower baseline NIH Stroke Scale, shorter procedure times and revascularization to a TIMI score of 2 to 3 also were linked to improved outcomes.
Multivariable analysis adjusted for age, baseline NIH Stroke Scale and status after revascularization indicated an association between aspiration time and 90-day outcomes (P = .003), with a greater risk for poor outcome with increasing aspiration time.
“As each new generation of devices provides improved tools for our treatment arsenal, we are able to adjust our approach to maximize efficiencies and results for our patients,” Donald Frei, MD, president of the Society of NeuroInterventional Surgery and neurointerventionalist at Swedish Medical Center in Englewood, Colorado, said in a press release. “Thankfully, each generation … has proven to reduce procedure time, which raises the chance of a successful operation.” – by Adam Taliercio
Reference:
Frei D, et al. Implementation of new technological advances of endovascular treatment in acute ischemic stroke provides overall improvement in procedural times. Presented at: Society of NeuroInterventional Surgery Annual Meeting; July 27-30, 2015; San Francisco.

No comments:

Post a Comment